Budget Amount *help |
¥17,550,000 (Direct Cost: ¥13,500,000、Indirect Cost: ¥4,050,000)
Fiscal Year 2023: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2022: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2021: ¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2020: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
|
Outline of Final Research Achievements |
In this study, we genetically labeled skeletal progenitors and their daughter cells by using cell lineage analysis and visualized the behavior of skeletal progenitors at bone defect sites. Single-cell analysis revealed that skeletal progenitors exhibited a bidirectional differentiation to adipocytes as well as osteoblasts at the site of bone repair. Ligand-receptor analysis further identified candidate of signaling factors involved in this directional differentiation. Among them, CCL9 inhibitor had a positive impact on bone regeneration in vivo. These findings provide an insight into the regulatory mechanism of skeletal progenitor cells locally at the site of bone repair.
|